Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-20

Clinical Trial Update: Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome

View source ↗

Summary

Non-interventional study evaluating osilodrostat in patients with endogenous Cushing's syndrome is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Isturisa (osilodrostat)

Snippet

Sponsor: RECORDATI GROUP | Conditions: Endogenous Cushing's Syndrome | Status: ACTIVE_NOT_RECRUITING